Clinicopathologic characteristics and prognoses of gastric cancer in patients with a positive familial history of cancer

Journal of Clinical Gastroenterology

Volumn 36, Issue 1, 2003, Pages 30-33

  Lee, Wei Jei ^a   Hong, Rey Long ^a   Lai, I Ru ^a   Chen, Chaung Nien ^a   Lee, Po Huang ^a   Huang, Ming Tegh ^a,b  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NONE   (Taiwan)

Author keywords

Clinicopathologic characteristics; Family history; Gastric cancer

Indexed keywords

NEU DIFFERENTIATION FACTOR; PROTEIN P53; SCATTER FACTOR RECEPTOR; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANCER INCIDENCE; CANCER RISK; COHORT ANALYSIS; COLORECTAL CANCER; CONTROLLED STUDY; FAMILIAL CANCER; FAMILY HISTORY; FEMALE; GASTRECTOMY; GENE OVEREXPRESSION; GENETIC RISK; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPATHOLOGY; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; SEX RATIO; STOMACH CANCER; SURVIVAL RATE;

AGED; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; STOMACH NEOPLASMS;

EID: 0037213954     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004836-200301000-00010     Document Type: Article

References (19)

1. Boyle P. Global cancer burden. Lancet 1997;349:23-6.
2. Mecklin JP, Nordling S, Saario I. Carcinoma of the stomach and its heredity in young patients. Scand J Gastroenterol 1988;23:307-11.
3. Zangheiri G, Di Gregorio C, Sacchetti C. et al. Familial occurrence of gastric cancer in the 2-year experience of a population-based registry. Cancer 1990;66: 2047-51.
4. La Vecchia C, Negri E, Franceschi S, et al. Family history and the risk of stomach and colorectat cancer. Cancer 1992;70:50-5.
5. Inoue M, Tajima K, Yamamura Y, et al. Family history and subsite of gastric cancer: Data from a case-referent study in Japan. Int J Cancer 1998;76:801-5.
6. Ikeguchi M, Fukuda K, Oka S, et al. Clinicopathologic findings in patients with gastric adenocarcinoma with familial aggregation. Dig Surg 2001;18:439-43.
7. Takara E. Molecular mechanism of stomach carcinogenesis. J Cancer Res Clin Oncol 1993;119:265-72.
8. Chung YJ, Song JM, Lee JY, et al. Microsatellite instability-associated mutations associate preferentially with the intestinal type of gastric carcinomas in a highrisk population. Cancer Res 1994;54:3845-52.
9. Guiford P, Hopkins J, Harraway J, et al. E-cadherin germline mutations in familial gastric cancer. Nature 1998;392:402-5.
10. Japanese Research Society for Gastric Cancer. Classification of Gastric Carcinoma. First English Ed. Tokyo: Kanehara, 1995.
11. Lauren R. The two histologic main types of gastric carcinoma. Acta Pathol. Microbiol Scand 1965;64:31-4.
12. Lee WJ, Shun CT, Hong RL, et al. Overexpression of p53 predicts shorter survival in diffuse type gastric cancer. Br J Surg 1998;85:1138-42.
13. Lin JT, Wu MS, Shun CT, et al. Occurrence of microsatellite instability in gastric cancer is associated with enhanced expression of erbB-2 oncoprotein. Cancer Res 1995;55: 1428-30.
14. Caldas C, Carneiro F, Lynch HT, et al. Familial gastriccancer: Overview and guidelines for management. J Med Genet 1999:36: 873-03.
15. Lee WJ, Lin JT, Lee WC, et al. Clinicopathologic characteristics of Helicobacter Pylori seropositive gastric adenocarcinomas. J Clin Gastroenterol 1995;21:203-7.
16. Lee WJ, Lee WC, Hong SJ, et al. Survival after resection of gastric cancer and prognostic relevance of systematic lymph node dissection: 20 Years, experience in Taiwan. World J Surg 1995; 19:707-13.
17. Lehtola J. Family study of gastric carcinoma: With special reference to histologic types. Scand J Gastroenterol 1978; 13(suppl 30).
18. Nomura A. Stomach. In: Schottenfeld D, Fraumeni F Jr, eds. Cancer Epidemiology and Prevention. Philadelphia: W.B. Saunders, 1982:624-37.
19. Palli D, Galli M, Caporaso NE, et al. Family history and risk of stomach cancer in Italy. Cancer Epidemiol Biomarkers Prev 1994;3:15-8.